Key facts
- Notable investors include Fulcrum Equity Partners, o15 Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Texas Endovascular Associates
- ·The full record, as it builds
Funding rounds
No funding rounds for Texas Endovascular Associates are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Texas Endovascular Associates
Provider of minimally invasive vascular treatments intended to serve patients with venous and arterial disorders across Texas. The company performs outpatient procedures such as radiofrequency ablation, sclerotherapy, ultrasound-guided evaluations and embolization techniques, thereby offering targeted care for conditions like varicose veins, spider veins and peripheral artery disease with reduced recovery time.
- Sector
- Healthcare
- HQ
- Houston, TX, United States
- Founded
- 2015
- Employees
- 33
- Website
- texaseva.com/
- Ownership
- Privately Held (backing)
Texas Endovascular Associates doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Texas Endovascular Associates shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Texas Endovascular Associates in its N-PORT filings yet. We sweep new filings monthly.